Chemically Reactive Nucleotide Analogs for Specific Conjugation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional nucleic acid detection and manipulation methods rely on enzyme-assisted techniques that suffer from low product yields, inefficiency, and low specificity due to multiple reactive groups, leading to high costs and time consumption.

Innovation Solution

The use of chemically reactive nucleotide analogs with alkyne groups, such as 3'-O-propargyl nucleotides, that allow for specific and efficient chemical conjugation, enabling downstream manipulation of nucleic acids through click chemistry reactions without inhibiting subsequent enzymatic processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If enzyme-assisted methods are used to append tags to target DNA, then the linkages are natural and allow further manipulation, but the methods have low product yields, inefficient reactions, and low specificity

Engineering Contradiction:
Improvelinkage naturalness and manipulabilityVSAvoidproduct yield and reaction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent replaces enzyme-assisted chemical conjugation methods with direct chemical conjugation using nucleotide analogs containing chemically reactive groups. Instead of relying on enzymatic mechanisms (ligase, polymerase), the invention uses chemical reactions between reactive groups on the nucleotide analogs and complementary groups on target molecules to achieve conjugation. This substitution maintains the ability to manipulate conjugated products while dramatically improving reaction efficiency and specificity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent modifies the chemical parameters of nucleotide analogs by incorporating specific reactive groups (alkynes, azides, cyclooctynes) at defined positions. These chemical parameter changes enable selective and efficient conjugation reactions. The reactive groups are strategically positioned to facilitate specific chemical bonds while maintaining compatibility with biological systems, thus resolving the contradiction between reaction efficiency and manipulability.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional chemical covalent linkages are used, then conjugation is achieved, but the linkages are not recognized by biological catalysts, limiting downstream manipulation

Engineering Contradiction:
Improveconjugation efficiencyVSAvoiddownstream manipulability
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent uses chemically reactive groups (such as alkynes, azides, cyclooctynes) as intermediary elements that bridge the gap between conventional chemical conjugation and biological compatibility. These reactive groups form stable covalent bonds through efficient chemical reactions while being designed to be compatible with biological systems. The intermediaries enable both efficient conjugation and subsequent enzymatic manipulation by maintaining natural molecular recognition.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates composite nucleotide analogs that combine conventional nucleotide structures with chemically reactive groups. These composite molecules integrate the benefits of efficient chemical conjugation (from the reactive groups) with the compatibility of natural nucleic acid structures. The composite design allows the conjugated products to be recognized and manipulated by biological catalysts while maintaining the efficiency of chemical bonding.

Inventive Principle:
Principle #40Composite materials

3Reliability

If reversible terminators with capping moieties are used, then polymerase reaction is terminated, but additional deprotection and purification steps are required

Engineering Contradiction:
Improvepolymerase reaction terminationVSAvoidnumber of process steps
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the need for separate deprotection and purification steps by incorporating the termination function directly into the nucleotide analog structure. The chemically reactive groups on the nucleotide analogs provide irreversible termination of polymerase reactions without requiring removable capping moieties. This extraction of unnecessary steps simplifies the overall process while maintaining reliable reaction termination.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The nucleotide analogs with chemically reactive groups provide self-terminating functionality that eliminates the need for additional processing steps. The reactive groups inherently provide the termination mechanism through their chemical properties, allowing the system to serve itself without external intervention for deprotection or purification. This self-service approach reduces process complexity while ensuring reliable termination.

Inventive Principle:
Principle #25Self-service

4Reliability

If nucleotide analogs with 3' blocking groups are used, then polymerase reaction is terminated, but subsequent enzymatic reactions are inhibited

Engineering Contradiction:
Improvepolymerase reaction terminationVSAvoidenzymatic reaction inhibition
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies local quality by placing chemically reactive groups at specific locations (3' position) on the nucleotide analogs. This localized modification provides termination functionality at the critical 3' end where polymerase activity occurs, while the rest of the nucleotide structure remains compatible with enzymatic processes. The reactive groups are positioned to terminate polymerization without generating harmful effects that would inhibit subsequent enzymatic reactions.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent converts the potentially harmful effect of 3' blocking groups into a beneficial termination mechanism. By using chemically reactive groups that form stable bonds, the invention achieves reliable polymerase termination without the harmful inhibition of conventional blocking groups. The reactive groups provide a positive benefit (controlled termination) while avoiding the negative effect (enzymatic inhibition) associated with traditional approaches.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides nucleic acids that can be efficiently manipulated and sequenced with high specificity and yield, reducing costs and time, while allowing for the use of nucleic acids in various applications without impairing enzymatic reactions.

Implementation Method 1

The use of chemically reactive nucleotide analogs with alkyne groups, such as 3'-O-propargyl nucleotides, that allow for specific and efficient chemical conjugation, enabling downstream manipulation of nucleic acids through click chemistry reactions

Methodology Applied
Scientific EffectClick chemistry: Chemical Bonding

Data Source

PatentEP3036248B1Nucleotide analogs
Publication Date: 2020.05.27 ABBOTT MOLECULAR INC
  • EP3036248B1 patent drawingFigure 1
  • EP3036248B1 patent drawingFigure 2
  • EP3036248B1 patent drawingFigure 3A

AI summary

Provided herein is technology relating to the manipulation and detection of nucleic acids, including but not limited to compositions, methods, and kits related to nucleotides comprising a chemically reactive linking moiety.